Skip to main content Skip to main navigation menu Skip to site footer

Correlation between nail psoriasis severity index score with quality of life in nail psoriasis

  • Abdul Arif ,
  • Irma Damayanti Roesyanto Mahadi ,
  • Ariyati Yosi ,


Abstract

Background: Psoriasis is a recurring chronic inflammatory disease, which can involve the skin, nails and joints. Nail psoriasis occurred in 50% of psoriasis patients. Nail psoriasis can interfere with the quality of life (QoL) due to its physical, mental, and social impacts. To determine the correlation between Nail Psoriasis Severity Index (NAPSI) score and QoL in nail psoriasis patients.

Methods: This was a correlative analytical study with a cross-sectional approach that involved nail psoriasis subjects aged ≥18 years. Data accessed from the recording of basic data. The examination of subjects included an assessment of NAPSI scores and the Nail Psoriasis Quality of Life (NPQ10) questionnaire. Statistical analyses were performed using Pearson’s correlation coefficients, with P<0.05 was considered statistically significant.

Results: A total of 26 subjects with nail psoriasis, with the highest proportion, were female (57.7%), age group of 48–57 years (34.6%), duration of psoriasis >5 years (76.9%), NAPSI score 81-100 (30.8%), the mean NAPSI score was 89.42±32.01, and the mean NPQ10 score was 6.96±3.30. There was a significant moderate positive correlation between the NAPSI score and QoL (r=0.632, p=0.001).

Conclusion: The higher the NAPSI scores, the worse the quality of life for nail psoriasis patients.

Keywords: nail psoriasis NAPSI NPQ10 quality of life

References

  1. Gudjonsson JE, Elder JT. Psoriasis. In: Kang S, Amagai , Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick's Dermatology 9th Ed. New York: McGraw-Hill Companies;2019:457-97.
  2. World Health Organization. Global Report on Psoriasis. Switzerland: World Health Organization, 2016.
  3. Putri DU, Effendy E, Roesyanto-Mahadi ID. Perbandingan Kadar Kortisol dalam Serum Penderita Psoriasis Vulgaris dengan Bukan Penderita Psoriasis Vulgaris. MDVI. 2018;45(2):71-5.
  4. Kuchekar AB, Pujari RR, Kuchekar SB, Dhole SN, Mule PM. Psoriasis: Comprehensive review. Int J of Pharm & Life Sci (IJPLS). 2011;6:857-77.
  5. Rich P, Scher RK. Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2013;49(2):206-12.
  6. Kacar N, Ergin S, Erdogen BS. The Comparison of Nail Psoriasis Severity Index with a less time-consumsing qualitative system. JEADV. 2008; 22: 219-22.
  7. Rajashekar S, Vellaisamy SG, Manickam N, Gopalan K, Kandasamy M. Prevalence of nail changes in patients with psoriasis and correlation of NAPSI (Nail Area Psoriasis Severity Index) with BSA (Body Surface Area). IP Indian Journal of Clinical and Experimental Dermatology. 2018;4(2):116-22.
  8. Velden HM, Klaassen K, Kerkhof P, Pasch MC. The Impact of Fingernail Psoriasis on Patients Health Related and Disease - Specific Quality of Life. Dermatology. 2014;229:76-82.
  9. Ortonne JP, Baran R, Corvest M, Schmitt C, Voisard JJ, Taieb C. Development and validation of nail psoriasis quality of life scale (NPQ10). JEADV. 2010;24:22-7.
  10. Radtke MA, Langenbruch AK, Schafer I, Herberger K, Reich K, Augustin M. Nail Psoriasis as a Severity Indicator: results from the PsoReal study. Patient Related Outcome Measure. 2011;7(2):1-6.
  11. Klaassen K, Kerkhof PCM, Pasch MC. Nail Psoriasis, The Unknown Burden of Disease. JEADV. 2014;28(12):1690-5
  12. Hongbo Y, Thomas CL, Harisson MA, Salek Ms, Finlay AY. Translating the Science of Quality of Life into Practice: What do Dermatology Life Quality Index Score Mean? Journal of Investigative Dermatology. 2009;125:659-64.
  13. Choi JW, Kim B, Seo E, Youn SW. Identification of Nail Features Associated with Psoriasis Severity. Journal of Dermatology. 2017;44(2):147-53.
  14. Baran R. The Burden of Nail Psoriasis: An Introduction. Dermatology. 2010;221(1):1-5.
  15. Schons KRS, Beck MO, Beber AAC, Monticielo OA. Nail involvement in adult patients with palque-type psoriasis: prevalence and clinical feature. An Bras Dermatol. 2015; 90(3): 314-9.
  16. Prabhakar V, Joy B, Thyvalappil A, Sridharan R, Sreenivasan A, Mathew P. Prevalence, clinical profile, and severity of nail involvement in psoriasis – A hospital-based cross-sectional study from a tertiary care centre in North Kerala. J Skin Sex Transm Dis. 2019;1(2):72-6.
  17. Kokolakis G, Bachmann F, Wolk K, Sabat R, Philipp S. Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy. Acta Derm Venereol. 2020;100:adv00214.
  18. Kyriakou A, Patsatsi A, Sotiriadis D. Quality of life and severity of skin and nail involvement in patients with plaque psoriasis. EJD. 2014;24(5):623-4.
  19. Darjani A, Nafezi R, Moladoust H, Eftekhari H, Nejad KG, Rafiei R, Alizadeh N, Azimi SZ. Nail Involvements as an Indicator of Skin Lesion Severity in Psoriatic Patients. Acta Dermatovenerol Croat. 2018;26(4):307-13.
  20. Prevezas C, Katoulisa A.C, Papadavid E, Panagakis P, Rigopoulos D. Short-Term Correlation of the Psoriasis Area Severity Index, the Nail Psoriasis Area Severity Index, and the Dermatology Life Quality Index, before and after Treatment, in Patients with Skin and Nail Psoriasis. Skin Appendage Disord. 2019;5:344-9.
  21. Dogra A, Arora AK. Nail psoriasis; the journey so far. Indian Journal of Dermatology. 2014;59(4):319-33.
  22. Daulatabad D, Grover C, Kashyap B, Dhawan AK, Singal A, Kaur IR. Clinical and serological characteristics of nail psoriasis in Indian patients: A cross-sectional study. IJDVL. 2017;83(6):650-5.
  23. Klaassen K, Kerkhof P, Bastiaens, 85. Scoring Nail Psoriasis. J Am Acad Dermatol. 2014;70(6):1061-6.
  24. Robati RM, Toossi T, Roodsari MR, Khalilazar S, Abolhasani E, Namazi N, et al. Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment. Sci World J. 2013;28(2013):921819
  25. Marina EM, Botar-Jid C, Bolboaca SD, Roman II, Senila CS, Mihu CM, Tataru DA. Patterns of Clinical Nail Appearances in Patients With Cutaneous Psoriasis. Clujul Medical. 2017;90(1):22-7.
  26. Hallaji Z, Babaeijandaghi F, Akbarzadeh M, Seyedi SZ, Barzegari M, Noormohammadpour P, et al. A significant association exists between the severity of nail and skin involvement in psoriasis. J Am Acad Dermatol. 2012;66(1):e12-3.
  27. Cakmur H, Dervis E. The relationship between quality of life and the severity of psoriasis in Turkey. Eur J Dermatol. 2015;25(2):169-76.
  28. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 2019; 20:4347.
  29. Jacoeb TNA. Psoriasis Gambaran klinis dan Penilaian Keparahan. In: Tjarta A, Sularsito A, Kurniati DD, and Rihatmaja R. Metode Diagnostik dan Penatalaksanaan Psoriasis dan Dermatitis Seboroik. Jakarta: FK UI;2003:1-13.

How to Cite

Arif, A., Roesyanto Mahadi, I. D., & Yosi, A. (2021). Correlation between nail psoriasis severity index score with quality of life in nail psoriasis. Bali Medical Journal, 10(1), 256–260. https://doi.org/10.15562/bmj.v10i1.2198
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
18

Share

Search Panel

Abdul Arif
Google Scholar
Pubmed
BMJ Journal

Irma Damayanti Roesyanto Mahadi
Google Scholar
Pubmed
BMJ Journal

Ariyati Yosi
Google Scholar
Pubmed
BMJ Journal